本页面由Tiger Trade Technology Pte. Ltd.提供服务

再鼎医药

24.59
-0.4000-1.60%
盘后:24.07-0.5200-2.11%16:05 EDT
成交量:52.45万
成交额:1,299.28万
市值:27.63亿
市盈率:-14.44
高:25.00
开:24.88
低:24.51
收:24.99
52周最高:32.76
52周最低:15.96
股本:1.12亿
流通股本:9,711.04万
量比:0.61
换手率:0.54%
股息:- -
股息率:- -
每股收益(TTM):-1.7030
每股收益(LYR):-1.6026
净资产收益率:-26.91%
总资产收益率:-14.75%
市净率:4.55
市盈率(LYR):-15.34

数据加载中...

2025/08/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/08/07

重要事件披露

Form 8-K - Current report
2025/07/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/18

重要事件披露

Form 8-K - Current report
2025/06/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/08

重要事件披露

Form 8-K - Current report